Determining that a vaccine will be a safe and effective response to an infectious disease starts with laboratory testing of a scientific concept. It then moves to animal and human testing. This session will explore the development and clinical trial processes, using examples of the COVID-19 vaccines to improve understanding.
- Clinical Trials
Michael L. Gruver, Senior Corporate Counsel, Pfizer, Inc.
Jonathan Walland, Senior Corporate Counsel, Pfizer, Inc.
This session was recorded as part of FDLI’s Virtual Fundamentals of Vaccine Regulation Course in February 2021.